Anavex Life Sciences Corp. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-05-15. Between them they name 2 people, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Felix Lauscher, Chief Executive Officer
On May 11, 2026, Felix Lauscher, who had held the title of Chief Operating Officer of Anavex Life Sciences Corp. (the "Company") since March 1, 2026, departed from the Company as part of a broader reorganization of duties at the Company following the appointment of Dr. Terrie Kellmeyer as the Company's Interim Chief Executive Officer.
Appointed: Terrie Kellmeyer, Chief Executive Officer
On May 4, 2026, the Board appointed Terrie Kellmeyer, PhD as the Company's Interim Chief Executive Officer.
Find people with the same kind of experience as the Chief Executive Officer at Anavex Life Sciences Corp., with the record behind each one.
Find candidates like Chief Executive Officer at Anavex Life Sciences Corp.New leaders review vendors and budgets in their first months. Get an alert the next time Anavex Life Sciences Corp. is in the news or changes leadership.
Get an alert when Anavex Life Sciences Corp. changes leadershipTools for this story
Each opens in a new tab, filled in for Anavex Life Sciences Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.